Showing results (471-480 of 726) with videos related to
Sort By:
Pageof 73
Anti-Cancer Drugs|September 23, 2003
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' StudyM S Stratton, M E Reid, G Schwartzberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2014
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancerLee S Schwartzberg, Fernando Rivera, Meinolf Karthaus, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 18, 2024
The Influence of High Body Mass Index (BMI > 35 kg/m2) on Apixaban Plasma Concentration in Patients with Atrial FibrillationMay Hilu, Mariana Issawy, Raul Colodner, et al.Cell Reports|April 11, 2026
A Rasa3-Gαi signaling axis orchestrates B lymphocyte trafficking into and through lymphoid organsChung Park, Il-Young Hwang, Kathleen Harrison, et al.Immunity|February 16, 2010
Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84Jennifer L Cannons, Hai Qi, Kristina T Lu, et al.Cancer Chemotherapy and Pharmacology|March 17, 2015
Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancerNiall Tebbutt, Dusan Kotasek, Howard A Burris, et al.Journal of Pain and Symptom Management|April 15, 2003
The Zero Acceptance of Pain (ZAP) Quality Improvement Project: evaluation of pain severity, pain interference, global quality of life, and pain-related costsBarry V Fortner, Theodore A Okon, Jeri Ashley, et al.Future Oncology (London, England)|December 15, 2025
Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trialRichard M Zuniga, Ari VanderWalde, Lee S Schwartzberg, et al.Journal of Cell Science|September 10, 2020
LFA-1 signals to promote actin polymerization and upstream migration in T cellsNathan H Roy, Sarah Hyun Ji Kim, Alexander Buffone, et al.Cancer Chemotherapy and Pharmacology|December 3, 2003
Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancerP Kellie Turner, Janet A Houghton, Istvan Petak, et al.Pageof 73